EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
Phase 2
Completed
- Conditions
- Hematologic Diseases
- Interventions
- Procedure: chemotherapy and blood stem cell transplantation
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 32
- Registration Number
- NCT00208962
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Critical Congenital Heart Defect (CHD) Outcomes in Children
Terminated
- Conditions
- Congenital Heart Disease
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 150
- Registration Number
- NCT00208689
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Calcium and Vitamin D vs Markers of Adenomatous Polyps
Phase 2
Completed
- Conditions
- Colorectal Adenomatous Polyps
- Interventions
- Dietary Supplement: CalciumDietary Supplement: Vitamin D3Dietary Supplement: Calcium and vitamin D3 combinedDrug: Placebo
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 92
- Registration Number
- NCT00208793
- Locations
- 🇺🇸
The Emory Clinic, Division of Digestive Diseases, Atlanta, Georgia, United States
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Emory University
- Target Recruit Count
- 1467
- Registration Number
- NCT00208871
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Hypernet- Hypertension Screening
Terminated
- Conditions
- Asymptomatic Hypertension
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-20
- Lead Sponsor
- Emory University
- Target Recruit Count
- 100
- Registration Number
- NCT00208845
Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-19
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT00209066
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
Resynchronization Therapy in Young Patients With and Without CHD
Completed
- Conditions
- Dilated CardiomyopathyPediatric
- Interventions
- Other: congestive heart failure patients
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT00208806
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-12-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT00209027
- Locations
- 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
Phase 2
Terminated
- Conditions
- Esophageal Diseases
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-09-09
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT00208936
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Spironolactone in Patients With Single Ventricle Heart
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 12
- Registration Number
- NCT00211081
- Locations
- 🇺🇸
Emory Clinic, Atlanta, Georgia, United States